Interferon-alpha (topical lozenges) vs placebo
Total number of oral ulcers · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Interferon-alpha (topical; hydrogel or lozenges) showed no clear difference in total number of oral ulcers compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for managing oral ulcers in Behçet's disease 2014 · Cochrane All outcomes24 weeks (duration of treatment)MD 1.50 [-10.43, 13.43]1 study · 61 participantsGRADE not reported